Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr-Jun;48(2):217-225.
doi: 10.12865/CHSJ.48.02.12. Epub 2022 Jun 30.

Biocompatibility Studies on a Collagen-Hydroxyapatite Biomaterial

Affiliations

Biocompatibility Studies on a Collagen-Hydroxyapatite Biomaterial

Oana-Liliana Filip Ionescu et al. Curr Health Sci J. 2022 Apr-Jun.

Abstract

The current treatment of osteomyelitis includes systemic antibiotic therapy and a debridement procedure of the formed biofilm and necrotic tissue. Moreover, cements and three-dimensional scaffolds are used both for the delivery of therapeutic agents and as fillers for bone defects. The aim of our research was to test, on cellular cultures, the biocompatibility of a previously synthesized microporous biocomposite containing hydroxyapatite and a collagen matrix including a therapeutic agent (ciprofloxacin and gentamicin). The scaffold was obtained by direct mineralization namely co-precipitation of hydroxyapatite on a collagen matrix.

Keywords: Biocomposite; biocompatibility; collagen-hydroxyapatite.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Figure 1
Figure 1
SEM images for the scaffolds tested: A. Col-HA, B. Col-HA-Gentamicin, C. Col-HA-Ciprofloxacin
Figure 1
Figure 1
SEM images for the scaffolds tested: A. Col-HA, B. Col-HA-Gentamicin, C. Col-HA-Ciprofloxacin
Figure 1
Figure 1
SEM images for the scaffolds tested: A. Col-HA, B. Col-HA-Gentamicin, C. Col-HA-Ciprofloxacin
Figure 2
Figure 2
Cytotoxicity evaluation of Col-HA scaffolds both with and without antibiotics (ciprofloxacin and gentamicin) using the MTS test. A. Sample images after the MTS reaction and supernatant removal. B.Graphic representation of the absorbance signal obtained following the MTS reaction
Figure 3
Figure 3
Mesenchymal stem cells viability after being cultured together with the Col-HA scaffold. Calcein (green) and ethidium homodimer-1 (red) were used to stain the viable cells and the dead cells, respectively inside the cellular culture. Hoechst was used to stain the nuclei. The upper image represents an overlap of images taken on 3 fluorescence channels (calcein/FITC+EthD-1/TxRed+Hoechst/DAPI). Below the first image are two decomposed images: left-calcein / FITC and right-EthD-1/TxRed+Hoechst/DAPI). Scale=100μm
Figure 4
Figure 4
Viability test performed on mesenchymal stem cells stained with calcein and co-cultivated with the scaffolds. After three days the samples were evaluated using the fluorescence microscope. Cell nuclei were identified by Hoechst labelling on the DAPI channel (left)
Figure 5
Figure 5
Cell adhesion analysis after staining MSC with AlexaFluor488 phalloidin which labels actin cytoskeleton (green); cell nuclei were stained with Hoechst (blue). The images were obtained using the TissueFAXSiPlus system which automatically scans the entire surface of the samples and then renders a virtual reconstruction of the sample (left); images on the right side represent selected detailed visual fields
Figure 6
Figure 6
SEM images of the MSC morphology 14 days after cell culture in osteoinduction medium compared to expansion medium
Figure 7
Figure 7
Analysis of the alkaline phosphatase enzymatic activity after 14 days of cultivating MSC in osteoinduction medium (OIM) compared to expansion medium (DMEM) by incubating samples with NBT-BCIP substrate (the result of the colorimetric reaction is highlighted in purple)

Similar articles

Cited by

References

    1. Macha IJ, Cazalbou S, Ben-Nissan B, Harvey KL, Milthorpe B. Marine structure derived calcium phosphate-polymer biocomposites for local antibiotic delivery. Mar Drugs. 2015;13(1):666–680. - PMC - PubMed
    1. Ferguson J, Alexander M, Bruce S, O'Connell M, Beecroft S, McNally M. A retrospective cohort study comparing clinical outcomes and healthcare resource utilisation in patients undergoing surgery for osteomyelitis in England: a case for reorganising orthopaedic infection services. J Bone Jt Infect. 2021;28;6(5):151–163. - PMC - PubMed
    1. Kołodziejska B, Kaflak A, Kolmas J. Biologically Inspired Collagen/Apatite Composite Biomaterials for Potential Use in Bone Tissue Regeneration-A Review. Materials (Basel) 2020;13(7):1748–1748. - PMC - PubMed
    1. Thirumalai J, editor. Hydroxyapatite-Advances in Composite Nanomaterials,Biomedical Applications and Its Technological Facets. Rijeka: InTech; 2018. pp. 109–109.
    1. Ciocilteu MV, Mocanu AG, Mocanu A, Ducu C, Nicolaescu OE, Manda VC, Turcu-Stiolica A, Nicolicescu C, Melinte R, Balasoiu M, Croitoru O, Neamtu J. Hydroxyapatite-ciprofloxacin delivery system: Synthesis, characterisation and antibacterial activity. Acta Pharm. 2018;68(2):129–144. - PubMed

LinkOut - more resources